mHealth Apps Market Size, Share & Trends Analysis Report By Type (Medical Apps, Fitness Apps), By Platform (Android, iOS), By Region, And Segment Forecasts, 2024 - 2030
mHealth Apps Market Growth & Trends
The global mHealth apps market size is expected to reach USD 86.37 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.9% from 2024 to 2030. The growing reach of the internet & smartphones, coupled with the increasing adoption of mobile health applications among medical practitioners & patients, contributes significantly to the market growth. An increasing awareness of lifestyle improvement & personal health and wellness drives the market. In addition, the rapid growth of remote healthcare services fuels mobile health application adoption. Moreover, physicians' increasing use of mHealth applications to enhance patient engagement and treatment outcomes is expected to boost their adoption further.
Smartphones have evolved from devices of communication & entertainment to devices that can monitor health and fitness. Mobile applications for smartphones have made life easy by making it convenient to perform daily activities. Some companies are developing chatbot services for one-time consultations or basic medical inquiries. For instance, WeChat in China offers Chatbot services for basic medical inquiries in addition to other mobile health solutions, such as booking an appointment, accessing medical records, and paying medical bills. Thus, rising importance of mobile phones and mHealth for improving health outcomes & patient care will drive market growth. The rise of mHealth technologies, adoption of various strategies by players, and technological advancements have resulted in increased funding for digital health.
In addition, physicians with experience in company operations or investments invest in digital health startups. This is expected to have a positive impact on the market growth. For instance, in October 2023, in California, Cedar-Sinai launched a new mobile application that enables patients to access their experts for sick, chronic, and preventive care conveniently and promptly. This virtual healthcare service has been expanded to cater to the needs of the patient base. Furthermore, the surge in initiatives and investments supporting mHealth & digital health involves significant backing from venture capitalists, private equity firms, and healthcare organizations.
The global health-tech investment landscape witnessed a substantial boost in 2021, reaching over USD 44 billion, which represents a twofold increase compared to the previous year. This influx of capital underscores the growing importance of technological innovation in healthcare. Notably, large tech-enabled platform companies are emerging as key players, offering the potential to enhance hospital and health system efficiencies, rapidly scale operations, and modernize existing systems & delivery models. In addition, these platforms are positioned to play a pivotal role in addressing health equity concerns through a comprehensive and inclusive approach to healthcare delivery.
mHealth Apps Market Report Highlights
- The medical apps segment accounted for the largest revenue share in 2023 owing to continuous improvements in network infrastructure and network coverage
- The iOS platform segment dominated the market in 2023 due to high awareness among people regarding mHealth technologies and increased use of mHealth apps for disease management
- North America was the dominant regional market in 2023, in terms of revenue share
- The region’s growth can be attributed to favorable government initiatives, developments in coverage networks, advancements in healthcare IT infrastructure, and a rise in healthcare expenditure
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Platform
- 1.2. Estimates and forecast timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.2.1. Service type outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Landscape Snapshot
- Chapter 3. mHealth Apps Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. High penetration of smartphones
- 3.2.1.2. Favorable government initiatives
- 3.2.1.3. Growing adoption of mobile health applications
- 3.2.1.4. Increase in investments supporting mHealth & digital health
- 3.2.2. Market restraint analysis
- 3.2.2.1. Concerns related to data security
- 3.3. Case Study Analysis
- 3.3.1. Case Study 1: Kilkari: a mobile health service for mothers in India
- 3.3.2. Case Study 2: Momconnect: empowering mothers in south africa
- 3.3.3. Case Study 3: Integrating mobile technology with existing healthcare infrastructure to enhance healthcare accessibility
- 3.3.4. Case Study 4: Jhpiego’s mwater project
- 3.3.5. Case Study 5: A web platform for clinician & patient interaction
- 3.3.6. Case Study 6: European firms have created digital technologies that can scale up to offer solutions for clinical settings, remote care, health insurance, and patient-centered eHealth services
- 3.3.7. Case Study 7: SMS to promote medicines adherence in South Africa
- 3.3.8. Case Study 8: MPOWER: Improving HIV medication adherence in Rwanda
- 3.3.9. Case Study 9: Omada Health: Digital tools for weight loss and diabetes prevention
- 3.4. Business Environment Analysis
- 3.4.1. Industry Analysis - Porter’s
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- Chapter 4. mHealth Apps Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 4.1. Definitions and Scope
- 4.2. Type Segment Dashboard
- 4.3. Global mHealth Apps Market, by Service Type, 2018 to 2030
- 4.4. Medical Apps
- 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Women's Health Apps
- 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.2. Fitness & Nutrition Apps
- 4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.3. Menstrual Health
- 4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.4. Pregnancy Tracking & Postpartum Care Apps
- 4.4.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.5. Disease Management Apps
- 4.4.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.6. Menopause Apps
- 4.4.2.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2.7. Others
- 4.4.2.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Chronic Disease Management Apps
- 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3.2. Obesity Management Apps
- 4.4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3.3. Mental Health Management Apps
- 4.4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3.4. Diabetes Management Apps
- 4.4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3.5. Blood Pressure and ECG Monitoring Apps
- 4.4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3.6. Cancer Management Apps
- 4.4.3.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3.7. Other Chronic Disease Management Apps
- 4.4.3.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.4. Personal Health Record Apps
- 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.5. Medication Management Apps
- 4.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.6. Diagnostic Apps
- 4.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.7. Remote Monitoring Apps
- 4.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.8. Others (Pill Reminder, Medical Reference, Professional Networking, Healthcare Education)
- 4.4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Fitness Apps
- 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 5. mHealth Apps Market Segment Analysis, By Platform, 2018 - 2030 (USD Million)
- 5.1. Definitions and Scope
- 5.2. Platform Segment Dashboard
- 5.3. Global mHealth Apps Market by Platform Outlook, 2018 to 2030
- 5.4. Android
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD million)
- 5.5. iOS
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 6. mHealth Apps Market: Segment Analysis, by Region, by Type, by Platform, 2018 - 2030 (USD Million)
- 6.1. Regional Market Share Analysis, 2023 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.4. SWOT Analysis
- 6.5. North America
- 6.5.1. U.S.
- 6.5.1.1. Key country dynamics
- 6.5.1.2. Regulatory framework/ reimbursement structure
- 6.5.1.3. Competitive scenario
- 6.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5.2. Canada
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Europe
- 6.6.1. UK
- 6.6.1.1. Key country dynamics
- 6.6.1.2. Regulatory framework/ reimbursement structure
- 6.6.1.3. Competitive scenario
- 6.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.2. Germany
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.3. France
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Regulatory framework/ reimbursement structure
- 6.6.3.3. Competitive scenario
- 6.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.4. Italy
- 6.6.4.1. Key country dynamics
- 6.6.4.2. Regulatory framework/ reimbursement structure
- 6.6.4.3. Competitive scenario
- 6.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.5. Spain
- 6.6.5.1. Key country dynamics
- 6.6.5.2. Regulatory framework/ reimbursement structure
- 6.6.5.3. Competitive scenario
- 6.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.6. Norway
- 6.6.6.1. Key country dynamics
- 6.6.6.2. Regulatory framework/ reimbursement structure
- 6.6.6.3. Competitive scenario
- 6.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.7. Sweden
- 6.6.7.1. Key country dynamics
- 6.6.7.2. Regulatory framework/ reimbursement structure
- 6.6.7.3. Competitive scenario
- 6.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.8. Denmark
- 6.6.8.1. Key country dynamics
- 6.6.8.2. Regulatory framework/ reimbursement structure
- 6.6.8.3. Competitive scenario
- 6.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7. Asia Pacific
- 6.7.1. Japan
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Regulatory framework/ reimbursement structure
- 6.7.1.3. Competitive scenario
- 6.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7.2. China
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7.3. India
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7.4. Australia
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7.5. South Korea
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Regulatory framework/ reimbursement structure
- 6.7.5.3. Competitive scenario
- 6.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7.6. Thailand
- 6.7.6.1. Key country dynamics
- 6.7.6.2. Regulatory framework/ reimbursement structure
- 6.7.6.3. Competitive scenario
- 6.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.8. Latin America
- 6.8.1. Brazil
- 6.8.1.1. Key country dynamics
- 6.8.1.2. Regulatory framework/ reimbursement structure
- 6.8.1.3. Competitive scenario
- 6.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.8.2. Mexico
- 6.8.2.1. Key country dynamics
- 6.8.2.2. Regulatory framework/ reimbursement structure
- 6.8.2.3. Competitive scenario
- 6.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.8.3. Argentina
- 6.8.3.1. Key country dynamics
- 6.8.3.2. Regulatory framework/ reimbursement structure
- 6.8.3.3. Competitive scenario
- 6.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.9. MEA
- 6.9.1. South Africa
- 6.9.1.1. Key country dynamics
- 6.9.1.2. Regulatory framework/ reimbursement structure
- 6.9.1.3. Competitive scenario
- 6.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.9.2. Saudi Arabia
- 6.9.2.1. Key country dynamics
- 6.9.2.2. Regulatory framework/ reimbursement structure
- 6.9.2.3. Competitive scenario
- 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.3. UAE
- 6.9.3.1. Key country dynamics
- 6.9.3.2. Regulatory framework/ reimbursement structure
- 6.9.3.3. Competitive scenario
- 6.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.9.4. Kuwait
- 6.9.4.1. Key country dynamics
- 6.9.4.2. Regulatory framework/ reimbursement structure
- 6.9.4.3. Competitive scenario
- 6.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. Key company market share analysis, 2023
- 7.4. Company Profiles
- 7.4.1. Apple Inc.
- 7.4.1.1. Company overview
- 7.4.1.2. Financial performance
- 7.4.1.3. Product benchmarking
- 7.4.1.4. Strategic initiatives
- 7.4.2. Google Inc.
- 7.4.2.1. Company overview
- 7.4.2.2. Financial performance
- 7.4.2.3. Product benchmarking
- 7.4.2.4. Strategic initiatives
- 7.4.3. AirStrip Technologies, Inc.
- 7.4.3.1. Company overview
- 7.4.3.2. Financial performance
- 7.4.3.3. Product benchmarking
- 7.4.3.4. Strategic initiatives
- 7.4.4. Samsung Electronics Co. Ltd.
- 7.4.4.1. Company overview
- 7.4.4.2. Financial performance
- 7.4.4.3. Product benchmarking
- 7.4.4.4. Strategic initiatives
- 7.4.5. Veradigm LLC (Allscripts Healthcare Solutions)
- 7.4.5.1. Company overview
- 7.4.5.2. Financial performance
- 7.4.5.3. Product benchmarking
- 7.4.5.4. Strategic initiatives
- 7.4.6. Qualcomm Technologies, Inc.
- 7.4.6.1. Company overview
- 7.4.6.2. Financial performance
- 7.4.6.3. Product benchmarking
- 7.4.6.4. Strategic initiatives
- 7.4.7. AT&T
- 7.4.7.1. Company overview
- 7.4.7.2. Financial performance
- 7.4.7.3. Product benchmarking
- 7.4.7.4. Strategic initiatives
- 7.4.8. Orange
- 7.4.8.1. Company overview
- 7.4.8.2. Financial performance
- 7.4.8.3. Product benchmarking
- 7.4.8.4. Strategic initiatives
- 7.4.9. Teladoc Health, Inc.
- 7.4.9.1. Company overview
- 7.4.9.2. Financial performance
- 7.4.9.3. Product benchmarking
- 7.4.9.4. Strategic initiatives
- 7.4.10. AstraZeneca
- 7.4.10.1. Company overview
- 7.4.10.2. Financial performance
- 7.4.10.3. Product benchmarking
- 7.4.10.4. Strategic initiatives
- 7.4.11. Abbott
- 7.4.11.1. Company overview
- 7.4.11.2. Financial performance
- 7.4.11.3. Product benchmarking
- 7.4.11.4. Strategic initiatives
- 7.4.12. Sanofi
- 7.4.12.1. Company overview
- 7.4.12.2. Financial performance
- 7.4.12.3. Product benchmarking
- 7.4.12.4. Strategic initiatives
- 7.4.13. Johnson & Johnson Services, Inc.
- 7.4.13.1. Company overview
- 7.4.13.2. Financial performance
- 7.4.13.3. Product benchmarking
- 7.4.13.4. Strategic initiatives
- 7.4.14. Novartis AG
- 7.4.14.1. Company overview
- 7.4.14.2. Financial performance
- 7.4.14.3. Product benchmarking
- 7.4.14.4. Strategic initiatives
- 7.4.15. Pfizer Inc.
- 7.4.15.1. Company overview
- 7.4.15.2. Financial performance
- 7.4.15.3. Product benchmarking
- 7.4.15.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook